Supporting the Global Action Plan on antimicrobial resistance, a Global Surveillance System, GLASS, was launched 2016.

In this report Finland, Germany, Latvia, Lithuania, Norway, Poland, Russian Federation and Sweden share their experiences from early implementation of GLASS.

Major findings were that there were too many supportive documents developed by the WHO and that existing documents is focused on countries with no national surveillance, while there was less guidance for countries which already have national surveillance, and how such countries should move towards alignment with GLASS.

Despite this several countries pointed at opportunities for an added value with implementing GLASS, both at local and national levels, for improving and expanding existing surveillance.

The report may be of interest for decision-makers and health-care officials organizing national AMR surveillance and for countries in the rest of Europe and beyond preparing early implementation of GLASS.